Inventor · disambiguated record
Arron Hearn
Also filed as: HEARN ARRON · HEARN ARRON R · HEARN ARRON ROBERT
9 granted patents·6 pending applications·19 citations·filing 2014–2024
83Inventor score
Files withSYNTIMMUNE INC4IMMUNEXT INC3THE BRIGHAM AND WOMEN’S HOSPITAL INC2BRIGHAM & WOMENS HOSPITAL INC1NEUROSURJ RES & DEVELOPMENT LLC1
Top patents by PatentIndex Score
15 records- 0188US11059903B2Anti-PSMA antibodies, uses thereof and conjugates thereofPOLYTHERICS LTD·Filed 2017·Granted Jul 13, 2021·4 cites·31 claims
- 0286US10874738B2Anti-CD154 antibody having improved binding, functional and safety characteristicsIMMUNEXT INC·Filed 2016·Granted Dec 29, 2020·3 cites·10 claims
- 0385US11596689B2Methods of immunosuppression comprising administering an anti-CD154 antibodyIMMUNEXT INC·Filed 2020·Granted Mar 7, 2023·1 cites·22 claims
- 0482US11098130B1Antibodies and antibody fragments against the CD155 receptor and methods of use thereofNEUROSURJ RES & DEVELOPMENT LLC·Filed 2019·Granted Aug 24, 2021·6 cites·16 claims
- 0579US10626175B2Humanized affinity matured anti-FcRn antibodiesSYNTIMMUNE INC·Filed 2017·Granted Apr 21, 2020·2 cites·2 claims
- 0676US10822417B2Humanized affinity matured anti-FcRn antibodiesSYNTIMMUNE INC·Filed 2017·Granted Nov 3, 2020·2 cites·9 claims
- 0773US2024000929A1Anti-cd154 antibody having improved binding, functional and safety characteristics and use in human immunotherapyIMMUNEXT INC·Filed 2023·Application pending·0 cites
- 0871US9603911B2Ribotoxin molecules derived from sarcin and other related fungal ribotoxinsRES CORP TECH INC·Filed 2014·Granted Mar 28, 2017·1 cites·28 claims
- 0970US2025074980A1Humanized and Affinity-Matured Anti-CEACAM1 AntibodiesTHE BRIGHAM AND WOMEN’S HOSPITAL INC·Filed 2024·Application pending·0 cites
- 1060US12173066B2Humanized and affinity-matured anti-CEACAM1 antibodiesBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Granted Dec 24, 2024·0 cites·23 claims
- 1159US2025388666A1Humanized and affinity-matured anti-ceacam1 antibodies and methods of useTHE BRIGHAM AND WOMEN’S HOSPITAL INC·Filed 2023·Application pending·0 cites
- 1259US2020207854A1HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIESSYNTIMMUNE INC·Filed 2020·Application pending·0 cites
- 1359US2020181262A1HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIESSYNTIMMUNE INC·Filed 2020·Application pending·0 cites
- 1450US2022056146A1Antibodies and Antigen Binding Fragments Against CD155 Methods of Use ThereofTASRIF PHARMACEUTICAL LLC·Filed 2021·Application pending·0 cites
- 1548US9976131B2Ribotoxin molecules derived from sarcin and other related fungal ribotoxinsRESEARCH CORPORATION TECH INC·Filed 2017·Granted May 22, 2018·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →